Tumor Control Outcomes After Hypofractionated and Single-Dose Stereotactic Image-Guided Intensity-Modulated Radiotherapy for Extracranial Metastases From Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Tumor Control Outcomes After Hypofractionated and Single-Dose Stereotactic Image-Guided Intensity-Modulated Radiotherapy for Extracranial Metastases From Renal Cell Carcinoma

Published:2012-04 Issue:5 Volume:82 Page:1744-1748
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Zelefsky Michael J.,Greco Carlo,Motzer Robert,Magsanoc Juan Martin,Pei Xin,Lovelock Michael,Mechalakos Jim,Zatcky Joan,Fuks Zvi,Yamada Yoshiya

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference26 articles.

1. Bax and Bak do not exhibit functional redundancy in mediating radiation-induced endothelial apoptosis in the intestinal mucosa;Rotolo;Int J Radiat Oncol Biol Phys,2008

2. High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions;Yamada;Int J Radiat Oncol Biol Phys,2008

3. Stereotactic radiosurgery for patients with “radioresistant” brain metastases;Brown;Neurosurgery,2008

4. The role of whole brain radiotherapy and stereotactic radiosurgery on brain metastases from renal cell carcinoma;Goyal;Int J Radiat Oncol Biol Phys,2000

5. Stereotactic radiosurgery for cerebral metastatic melanoma: Factors affecting local disease control and survival;Mori;Int J Radiat Oncol Biol Phys,1998

Cited by 194 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma—a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology;The Lancet Oncology;2024-05

2. SABR for oligometastatic renal cell carcinoma;Clinical and Translational Radiation Oncology;2024-03

3. Radiation therapy of renal cell carcinoma skeletal metastases – Does histologic subtype predict progression?;Clinical Surgical Oncology;2024-03

4. Stereotactic body radiation therapy for bone oligometastases;Cancer/Radiothérapie;2024-02

5. The role of radiation therapy for de novo metastatic bladder and renal cancers;Cancer/Radiothérapie;2024-02